Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

136 Years And Counting: Boehringer Ingelheim Sees Advantage In Private Structure

21 Jul 2021

• By Joseph Haas

Dawn over the Pharmalogical Research building at Biberach, Germany — • Source: Boehringer Ingelheim GmbH

Related Content

Numbers Crunched: Reviewing Biopharma's FY 2019 Performance

02 Dec 2020

US Capitol Capsule: Industry attack on 340B 'unsubstantiated,' safety net group charges

18 Feb 2013

Boehringer De-Risking Development With Computational Biology

21 Jul 2021

Boehringer Ingelheim: 1885 To Present

21 Jul 2021

Zoetis IPO values Pfizer animal health business at up to $15.8bn

23 Jan 2013

Amgen Gobbles Up Micromet In $1.16 Billion BiTE

26 Jan 2012

Bold Brandicourt Plots Mega Sanofi And Boehringer Animal, Consumer Asset Swap

15 Dec 2015

Boehringer Adds Yuhan’s First-In-Class Dual Agonist To NASH Portfolio

01 Jul 2019

Boehringer’s Philosophy Of Deal-Making: A Conversation With Ioannis Sapountzis And Scott DeWire

19 Jun 2020

BI Finds Right Fit For Digital Therapeutic Partnership With Click

11 Sep 2020

G1 Believes Boehringer Is Better Bet To Sell Trilaciclib

01 Jul 2020

Boehringer Reflects On Resilience Of Older Therapies

01 Apr 2021

BI Strengthens Research Efforts In IO Stromal Biology And Retinal Disease

14 May 2020

Deal Watch: Sanofi Teams Up With Biond On Novel Checkpoint Inhibitor

13 Jan 2021

Lilly/BI's Jardiance Scores A Win In Heart Failure Where Rivals Have Not

06 Jul 2021

Deal Watch: Genentech Gets Access To X-Chem’s DNA-Encoded Library Technology

04 Feb 2021

Boehringer Ingelheim To Focus On Precision Psychiatry In CNS

25 Mar 2021

Boehringer Ingelheim Backs R&D With Big Bucks

24 Mar 2021

Boehringer Ingelheim, Gubra Enter Third Obesity Deal

02 Mar 2021

BI’s Business Development Focus Remains On Early Collaboration

20 Jun 2018

Related Companies

Boehringer Ingelheim GmbH

AbbVie Inc.

Roche Holding AG

Novartis AG

Sanofi

Merck & Co., Inc.

Johnson & Johnson

Micromet, Inc.

Amgen, Inc.

Pfizer Inc.

Eli Lilly and Company

Yuhan Corporation

CDR-Life, Inc.

Bristol Myers Squibb Company

Bayer AG

Dyax Corp

Wyeth Pharmaceuticals

NBE Therapeutics AG

Gubra ApS

Lieber Institute for Brain Development

Cure Genetics Co., Ltd.

Click Therapeutics, Inc.

Additional Topics

Germany Europe Companies Business Strategies Leadership Commercial BioPharmaceutical Outlook 2022

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.